Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of a Canadian real-world cohort of metastatic castration-sensitive prostate cancer patients stratified by early PSA nadir.

Future oncology (London, England)·2026
Same author

Single-cell genomic analysis of cancer cells from one treatment-naïve patient with metastatic prostate cancer.

BMC genomic data·2026
Same author

Predicting clinically significant prostate cancer with or without digital rectal exam and MRI data using ClarityDX Prostate models.

NPJ digital medicine·2026
Same author

Mediation analysis of adherence to pelvic floor muscle training and weekly self-monitoring on urinary symptoms in men with localized prostate cancer: A secondary analysis of the Prostate Cancer-Patient Empowerment Program (PC-PEP) randomized controlled trial.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2026
Same author

Sustained-release opioid following open abdominal urologic surgery A randomized, controlled study.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada·2025
Same author

Metformin Active Surveillance Trial in Low-Risk Prostate Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025

Related Experiment Video

Updated: Nov 11, 2025

Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP
06:55

Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP

Published on: February 14, 2022

1.9K

Lymph node dissection during radical nephrectomy: A Canadian multi-institutional analysis.

Andrea Kokorovic1, Rodney H Breau2, Anil Kapoor3

  • 1The University of Texas MD Anderson Cancer Center, Houston, TX.

Urologic Oncology
|March 31, 2021
PubMed
Summary
This summary is machine-generated.

Lymph node dissection (LND) during radical nephrectomy for kidney cancer did not improve survival outcomes. This study found no survival benefit for LND, even in patients at high risk for nodal metastases.

Keywords:
Lymph node dissectionNephrectomyPredictorsPrognosisRenal cell carcinomaSurvival

More Related Videos

Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism
09:31

Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism

Published on: February 14, 2022

2.3K
Normothermic Ex Situ Heart Perfusion in Working Mode: Assessment of Cardiac Function and Metabolism
09:10

Normothermic Ex Situ Heart Perfusion in Working Mode: Assessment of Cardiac Function and Metabolism

Published on: January 12, 2019

13.4K

Related Experiment Videos

Last Updated: Nov 11, 2025

Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP
06:55

Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP

Published on: February 14, 2022

1.9K
Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism
09:31

Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism

Published on: February 14, 2022

2.3K
Normothermic Ex Situ Heart Perfusion in Working Mode: Assessment of Cardiac Function and Metabolism
09:10

Normothermic Ex Situ Heart Perfusion in Working Mode: Assessment of Cardiac Function and Metabolism

Published on: January 12, 2019

13.4K

Area of Science:

  • Urology
  • Oncology
  • Surgical Oncology

Background:

  • Radical nephrectomy is a standard treatment for renal cell carcinoma.
  • The role of lymph node dissection (LND) in improving survival outcomes remains debated.
  • Identifying patients who benefit from LND is crucial for optimizing treatment strategies.

Purpose of the Study:

  • To investigate the association between lymph node dissection (LND) performed during radical nephrectomy and survival outcomes in a large, multi-institutional cohort.
  • To evaluate the impact of LND on overall survival, recurrence-free survival, and cancer-specific survival.
  • To determine if LND provides a therapeutic benefit in patients with a higher probability of nodal metastases.

Main Methods:

  • Utilized data from the Canadian Kidney Cancer information system for patients with nonmetastatic renal cell carcinoma undergoing radical nephrectomy.
  • Employed propensity score matching techniques (quintile stratification, matched pairs, inverse probability weighting) to analyze associations between LND and survival.
  • Applied Cox models to assess the impact of lymph node removal on patient outcomes.

Main Results:

  • Out of 2,699 eligible patients, 812 (30%) underwent LND, with 88 (10.8%) having nodal metastases.
  • No significant association was found between LND and improved overall survival, recurrence-free survival, or cancer-specific survival across various propensity score analyses.
  • LND did not demonstrate a therapeutic benefit even in patients with a higher risk of nodal metastases, and the number of lymph nodes removed did not correlate with improved survival.

Conclusions:

  • Lymph node dissection at the time of radical nephrectomy for renal cell carcinoma is not associated with improved survival outcomes.
  • There was no observed benefit from LND in patients identified as high-risk for nodal metastases.
  • Further research is necessary to identify specific high-risk patient subgroups who might potentially benefit from LND.